ARCHIVES

Adding Topotecan To Standard Treatment Doesn’t Improve Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 33 No. 10 | October 29, 2010

Download PDF Visit The Full Archive

Related Articles

Afatinib Delays Tumor Growth In LUX-Head and Neck 1 Study

October 31, 2014

Hiring Freeze Squeezes NIH, NCI

August 3, 1979

SEER Expects To Lower Cancer Incidence Rates for Blacks by 3%

September 27, 2002

2006 demonstration project to pay $23 per office visit.

November 4, 2005

Funding opportunities listed.

April 30, 2004

More RFPs Coming On X-Ray imaging For Early Diagnosis, Including Sound

August 23, 1974